The Centers for Medicare & Medicaid Services has successfully negotiated agreements with two drug manufacturers to ...

Many other model organisms have significant trait-mapping ... association or selection mapping; identifying gene function and genomic variants; and testing likely variants for function.

Gene therapy is a very rapidly evolving space ... challenges involved with putting in place a new payment model. However, when you add in the approximate 1,500 patients treated globally over ...

Bluebird bio (NASDAQ:BLUE) and Vertex Pharmaceuticals (NASDAQ:VRTX) have entered into outcome-based agreements with the Centers for Medicare & Medicaid Services aimed at expanding patient access to ...

Gene therapies can be life-changing for people, but the high cost plus the burden of treatment remain barriers to access and ...

Researchers used mitochondrial gene editing to model genetic disorders in mice, revealing profound impacts on brain function, ...